SOP Guide for Pharma

Tablets: SOP for Content Uniformity Testing of Immediate Release Tablets – V 2.0

Auditor

Tablets: SOP for Content Uniformity Testing of Immediate Release Tablets – V 2.0

Standard Operating Procedure for Content Uniformity Testing of Immediate Release Tablets

Department Tablet
SOP No. SOP/TAB/093/2025
Supersedes SOP/TAB/093/2022
Page No. Page 1 of 6
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

To define the procedure for content uniformity testing of immediate release tablets, ensuring that the active pharmaceutical ingredient (API) is consistently distributed within each tablet and meets the required specifications.

2. Scope

This SOP applies to content uniformity testing for immediate release tablets, including the preparation of the sample, testing procedure, and acceptance criteria to ensure consistent API distribution across all tablets.

3. Responsibilities

4. Accountability

The QC Manager is accountable for ensuring that the content uniformity testing is conducted in compliance with this SOP. The QA Manager is responsible for reviewing the results and approving the batch for release.

See also  Tablets: SOP for Analytical Standards Preparation for Quality Control - V 2.0

5. Procedure

5.1 Sample Collection

  1. Collect a representative sample of tablets from the batch. The sample should consist of a minimum of 30 tablets, or as specified in the batch record or pharmacopeial guidelines.
  2. Ensure that the tablets are free from defects such as cracks, chips, or contamination.
  3. Label the sample appropriately for identification during testing.

5.2 Preparation of Sample

  1. Weigh a specified number of tablets (usually 10 tablets) and crush them into a fine powder using a clean mortar and pestle or a tablet grinder.
  2. Ensure that the tablet powder is homogeneous, with no visible clumps or aggregation.
  3. Accurately weigh an appropriate amount of the powder for dissolution in a suitable solvent or dissolution medium, following the test method outlined in the batch record or pharmacopeial guidelines.

5.3 Performing Content Uniformity Test

  1. Transfer the prepared sample into a suitable solvent or dissolution medium, ensuring complete dissolution of the tablet powder.
  2. Perform the assay of the API using a suitable analytical method, such as HPLC, UV spectrophotometry, or titration, depending on the characteristics of the API.
  3. Ensure that the sample is analyzed according to the pharmacopeial guidelines or internal testing protocols to determine the API content in each tablet.

5.4 Data Recording and Calculation

  1. Record the assay results for each tablet, including the concentration of the API and the calculated amount in each tablet (Annexure-1).
  2. Calculate the average API content of the tested tablets and the relative standard deviation (RSD) for the sample.
  3. Ensure that the individual tablet content does not vary by more than ±15% from the label claim (for 90% of the tablets tested) and that the average content is within 85%-115% of the label claim.
See also  Tablets: SOP for Microbial Limit Testing for Dispersible Tablets - V 2.0

5.5 Acceptance Criteria

  1. Ensure that the content uniformity test results meet the following acceptance criteria:
    • The content of 90% of the tablets must be within ±15% of the label claim.
    • The average content of the tablets must be within 85%–115% of the label claim.
  2. If any tablet fails to meet the acceptance criteria, investigate and document the findings in the deviation report (Annexure-2).
  3. Take corrective actions as necessary and perform re-testing if required.

5.6 Documentation and Record-Keeping

  1. Document all test results, including the assay results, calculations, and observations, in the batch record (Annexure-1).
  2. Ensure that all records are signed, dated, and stored according to the company’s record retention policy for future audits and inspections.
  3. Maintain all chromatograms, raw data, and assay results for future reference and audits.

5.7 Post-Test Cleanup

  1. Clean all equipment used for content uniformity testing, including sample containers, balances, and dissolution apparatus, according to the cleaning SOP to prevent contamination between tests.
  2. Ensure the laboratory equipment is properly maintained and calibrated for future use.
See also  Tablets: SOP for Particle Size Analysis in Slow-Release Tablets - V 2.0

6. Abbreviations

7. Documents

  1. Batch Record (Annexure-1)
  2. Deviation Report (Annexure-2)

8. References

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Batch Record

Batch Number Tablet Sample Sample Weight (g) API Content (%) Result
Batch 001 Tablet Sample 0.5 99.3% Pass

Annexure-2: Deviation Report

Deviation Date Batch Number Deviation Description Corrective Action Responsible Person
12/12/2025 Batch 001 API content variation in tablet samples Adjusted blending process and rechecked formulation John Doe

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated Testing Parameters Refined content uniformity protocols QA Head
Exit mobile version